Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (216) 216
Patent (150) 150
Newspaper Article (120) 120
Publication (26) 26
Book / eBook (19) 19
Dissertation (8) 8
Book Review (4) 4
Conference Proceeding (2) 2
Book Chapter (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
microbiology (125) 125
chemistry (124) 124
metallurgy (123) 123
biochemistry (115) 115
beer (112) 112
compositions thereof (112) 112
culture media (112) 112
enzymology (112) 112
microorganisms or enzymes (112) 112
mutation or genetic engineering (112) 112
propagating, preserving or maintaining microorganisms (112) 112
spirits (112) 112
vinegar (112) 112
wine (112) 112
humans (111) 111
human necessities (109) 109
hygiene (109) 109
medical or veterinary science (109) 109
preparations for medical, dental, or toilet purposes (103) 103
organic chemistry (95) 95
peptides (91) 91
female (87) 87
index medicus (72) 72
male (50) 50
adult (46) 46
animals (38) 38
motion pictures (37) 37
ghosts (36) 36
middle aged (30) 30
adolescent (29) 29
virology (29) 29
cancer (27) 27
human papillomavirus (26) 26
analysis (25) 25
mice (25) 25
aged (24) 24
papillomavirus infections (24) 24
oncology (22) 22
research (22) 22
immunology (21) 21
papillomavirus infections - prevention & control (20) 20
health aspects (19) 19
papillomavirus infections - virology (19) 19
proteins (19) 19
general tagging of cross-sectional technologies spanning over several sections of the ipc (18) 18
general tagging of new technological developments (18) 18
risk factors (18) 18
surgery (18) 18
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (18) 18
cervical cancer (17) 17
prevention (17) 17
infections (16) 16
young adult (16) 16
antibodies (15) 15
infectious diseases (15) 15
papillomaviridae - genetics (15) 15
uterine cervical neoplasms - prevention & control (15) 15
antibodies, viral - blood (14) 14
casings or constructional details of electric apparatus (14) 14
electric techniques not otherwise provided for (14) 14
electricity (14) 14
human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18 (14) 14
manufacture of assemblages of electrical components (14) 14
medical and health sciences (14) 14
medicin och hälsovetenskap (14) 14
printed circuits (14) 14
young-women (14) 14
care and treatment (13) 13
diagnosis (13) 13
identification (13) 13
mechanical engineering (13) 13
papillomaviridae - immunology (13) 13
papillomavirus vaccines - immunology (13) 13
specific therapeutic activity of chemical compounds ormedicinal preparations (13) 13
vaccines (13) 13
virus-like particles (13) 13
blasting (12) 12
heating (12) 12
hpv (12) 12
infection (12) 12
lighting (12) 12
risk (12) 12
vaccine (12) 12
viruses (12) 12
weapons (12) 12
women (12) 12
clinical trials (11) 11
expression (11) 11
follow-up studies (11) 11
immunization (11) 11
lesions (11) 11
papillomaviridae - isolation & purification (11) 11
randomized controlled-trial (11) 11
technical subjects covered by former us classification (11) 11
technical subjects covered by former uspc (11) 11
vaccination (11) 11
aged, 80 and over (10) 10
cervical-cancer (10) 10
double-blind method (10) 10
nucleic acids (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Art - Library use only (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Stacks (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Law (Bora Laskin) - Reserve desk (1) 1
OISE - Stacks (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Royal Ontario Museum - Far Eastern Egyptian (1) 1
Trinity College (John W Graham) - Reference (1) 1
University Archives - Archives (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (499) 499
French (43) 43
German (23) 23
Chinese (12) 12
Portuguese (7) 7
Icelandic (4) 4
Norwegian (4) 4
Danish (3) 3
Greek (3) 3
Slovenian (3) 3
Japanese (2) 2
Spanish (2) 2
Korean (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Developing an HPV vaccine to prevent cervical cancer and genital warts
by Bryan, Janine T
Vaccine, ISSN 0264-410X, 2007, Volume 25, Issue 16, pp. 3001 - 3006
Abstract The challenges of the journey from target identification through development of a prophylactic quadrivalent human papillomavirus (HPV) vaccine have... 
Allergy and Immunology | HPV vaccine | Gardasil | HPV virus-like particles | ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | POPULATION | L1 PROTEIN | Gardasil (R) | MAJOR CAPSID PROTEIN | IMMUNOLOGY | SACCHAROMYCES-CEREVISIAE | HUMAN-PAPILLOMAVIRUS TYPE-11 | RECURRENT RESPIRATORY PAPILLOMATOSIS | NEUTRALIZING EPITOPES | VIRUS-LIKE PARTICLES | EXPRESSION | Vaccination - standards | Papillomaviridae - drug effects | Humans | Uterine Cervical Neoplasms - epidemiology | Uterine Cervical Neoplasms - prevention & control | Condylomata Acuminata - epidemiology | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Sexually Transmitted Diseases, Viral - epidemiology | Sexually Transmitted Diseases, Viral - prevention & control | Papillomavirus Vaccines - adverse effects | Uterine Cervical Neoplasms - virology | Female | Papillomavirus Vaccines - immunology | Papillomavirus Vaccines - administration & dosage | Prevention | Proteins | Condyloma acuminatum | Vaccines | Papillomavirus infections | Cervical cancer | Cancer | Medical research | Human papillomavirus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine
by Bryan, Janine T and Buckland, Barry and Hammond, Jennifer and Jansen, Kathrin U
Current Opinion in Chemical Biology, ISSN 1367-5931, 06/2016, Volume 32, pp. 34 - 47
In 2006, the first human papillomavirus (HPV) virus-like particle (VLP) vaccine was licensed. Gardasil , the quadrivalent HPV 6, 11, 16 and 18 recombinant VLP... 
THERMAL-STABILITY | CONTROLLED-TRIAL | BIOPHYSICS | L1 PROTEIN | QUADRIVALENT HPV VACCINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MAJOR CAPSID PROTEIN | HUMAN GENITAL WARTS | INTRAEPITHELIAL NEOPLASIA | SACCHAROMYCES-CEREVISIAE | TRANSFORMATION IN-VIVO | CONDYLOMATA-ACUMINATA | Female | Vaccines, Virus-Like Particle - administration & dosage | Alphapapillomavirus - immunology | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - administration & dosage | Humans | Uterine Cervical Neoplasms - prevention & control | Papillomaviruses | Prevention | Vaccination | Vaccines | Papillomavirus infections | Recombinant proteins | Cervical cancer | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Modeling Host Genetic Regulation of Influenza Pathogenesis in the Collaborative Cross
by Ferris, Robert and Aylor, David and Bottomly, Daniel and Whitmore, Alan and Aicher, Lauri and Bell, Timothy and Bradel-Tretheway, Birgit and Bryan, Stirling and Buus, Ryan and Gralinski, Lisa and Haagmans, Bart and McMillan, Leonard and Miller, Darla and Rosenzweig, Elizabeth and Valdar, William and Wang, Jinxia and Churchill, Gary and Threadgill, David and McWeeney, Shannon and Katze, Michael and Pardo-Manuel de Villena, Fernando and Baric, Ralph and Heise, Mark
PL o S Pathogens (Online), ISSN 1553-7366, 02/2013, Volume 9, Issue 2, p. e1003196
textabstractGenetic variation contributes to host responses and outcomes following infection by influenza A virus or other viral infections. Yet narrow windows... 
LABORATORY MOUSE | COEXPRESSION NETWORK ANALYSIS | PANDEMIC VIRUS | MICROBIOLOGY | AGED MICE | MX1 GENE | QUANTITATIVE TRAIT LOCI | A-VIRUS-INFECTION | VIROLOGY | IMMUNE-RESPONSES | SUBSPECIFIC ORIGIN | PARASITOLOGY | GENOME-WIDE ASSOCIATION | Influenza, Human - pathology | Reassortant Viruses - pathogenicity | Species Specificity | Humans | Reassortant Viruses - genetics | Orthomyxoviridae Infections - genetics | Genetic Variation | Rodent Diseases - genetics | Recombination, Genetic | Female | Influenza, Human - virology | Rodent Diseases - pathology | Lung - pathology | Orthomyxoviridae Infections - pathology | Rodent Diseases - virology | Mice, Inbred Strains | Phenotype | Animals | Host-Pathogen Interactions - genetics | Influenza A virus | Virus Replication | Influenza, Human - genetics | Mice | Models, Genetic | Orthomyxoviridae Infections - virology | Crosses, Genetic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
by Muñoz, Nubia and Kjaer, Susanne K and Sigurdsson, Kristján and Iversen, Ole-Erik and Hernandez-Avila, Mauricio and Wheeler, Cosette M and Perez, Gonzalo and Brown, Darron R and Koutsky, Laura A and Tay, Eng Hseon and Garcia, Patricía J and Ault, Kevin A and Garland, Suzanne M and Leodolter, Sepp and Olsson, Sven-Eric and Tang, Grace W. K and Ferris, Daron G and Paavonen, Jorma and Steben, Marc and Bosch, F. Xavier and Dillner, Joakim and Huh, Warner K and Joura, Elmar A and Kurman, Robert J and Majewski, Slawomir and Myers, Evan R and Villa, Luisa L and Taddeo, Frank J and Roberts, Christine and Tadesse, Amha and Bryan, Janine T and Lupinacci, Lisa C and Giacoletti, Katherine E. D and Sings, Heather L and James, Margaret K and Hesley, Teresa M and Barr, Eliav and Haupt, Richard M and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2010, Volume 102, Issue 5, pp. 325 - 339
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital... 
AGED 16-26 YEARS | QUADRIVALENT VACCINE | ONCOLOGY | NEUTRALIZING EPITOPES | CLINICAL-TRIALS | DOUBLE-BLIND | TYPE-18 | VIRUS-LIKE PARTICLES | PROPHYLACTIC EFFICACY | RANDOMIZED CONTROLLED-TRIAL | CERVICAL INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Tumor Virus Infections - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Genital Diseases, Female - prevention & control | Sexually Transmitted Diseases - epidemiology | Alphapapillomavirus - immunology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Young Adult | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 11 - immunology | Tumor Virus Infections - epidemiology | Papillomavirus Vaccines - administration & dosage | Genital Diseases, Female - virology | Papillomavirus Infections - complications | Global Health | Papanicolaou Test | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Kaplan-Meier Estimate | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomavirus Vaccines - pharmacology | Tumor Virus Infections - prevention & control | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Sexual Partners | Prevention | Complications and side effects | Care and treatment | Young women | Research | Health aspects | Papillomavirus infections | Risk factors | Genital diseases, Female | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
by Dillner, Joakim and Kjaer, Susanne K and Wheeler, Cosette M and Sigurdsson, Kristján and Iversen, Ole-Erik and Hernandez-Avila, Mauricio and Perez, Gonzalo and Brown, Darron R and Koutsky, Laura A and Tay, Eng Hseon and García, Patricia and Ault, Kevin A and Garland, Suzanne M and Leodolter, Sepp and Olsson, Sven-Eric and Tang, Grace W.K and Ferris, Daron G and Paavonen, Jorma and Lehtinen, Matti and Steben, Marc and Bosch, F. Xavier and Joura, Elmar A and Majewski, Slawomir and Muñoz, Nubia and Myers, Evan R and Villa, Luisa L and Taddeo, Frank J and Roberts, Christine and Tadesse, Amha and Bryan, Janine T and Maansson, Roger and Lu, Shuang and Vuocolo, Scott and Hesley, Teresa M and Barr, Eliav and Haupt, Richard and Future I II Study Grp and FUTURE I/II Study Group and The FUTURE I/II Study Group and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
BMJ, ISSN 0959-8138, 2010, Volume 341, Issue 7766, pp. 239 - 239
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal... 
Warts | RESEARCH | Lesions | Neoplasia | Population control | Vaccination | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PARTICLE VACCINE | EXTERNAL GENITAL WARTS | CLINICAL-TRIALS | PREVENTION | TERMINOLOGY | INFECTION | HEALTH | CANCER | LESIONS | Double-Blind Method | Humans | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Carcinoma in Situ - prevention & control | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Young Adult | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Cancer Vaccines | Vulvar Neoplasms - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Urogenital Neoplasms - prevention & control | Papillomavirus Vaccines | Papillomavirus Infections: prevention & control | Basic Medicine | Condylomata Acuminata: prevention & control | Medical and Health Sciences | Medicin och hälsovetenskap | Urogenital Neoplasms: prevention & control | Mikrobiologi inom det medicinska området | Uterine Cervical Neoplasms: prevention & control | Vaginal Neoplasms: prevention & control | Carcinoma in Situ: prevention & control | Microbiology in the medical area | Cervical Intraepithelial Neoplasia: prevention & control | Medicinska och farmaceutiska grundvetenskaper | Vulvar Neoplasms: prevention & control
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
by Miller, Bryan W and Morton, Jennifer P and Pinese, Mark and Saturno, Grazia and Jamieson, Nigel B and McGhee, Ewan and Timpson, Paul and Leach, Joshua and McGarry, Lynn and Shanks, Emma and Bailey, Peter and Chang, David and Oien, Karin and Karim, Saadia and Au, Amy and Steele, Colin and Carter, Christopher Ross and McKay, Colin and Anderson, Kurt and Evans, Thomas R Jeffry and Marais, Richard and Springer, Caroline and Biankin, Andrew and Erler, Janine T and Sansom, Owen J
EMBO Molecular Medicine, ISSN 1757-4676, 08/2015, Volume 7, Issue 8, pp. 1063 - 1076
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer‐related mortality. Despite significant advances made in the treatment of other... 
pancreatic cancer | lysyl oxidase | collagen cross‐linking | animal models of cancer | Animal models of cancer | Collagen cross-linking | Lysyl oxidase | Pancreatic cancer | FIBROSIS | MEDICINE, RESEARCH & EXPERIMENTAL | DUCTAL ADENOCARCINOMA | BETA-CATENIN | FALSE DISCOVERY RATE | TRIAL | IMMUNOSUPPRESSION | collagen cross-linking | EXPRESSION | CARCINOMA | TENASCIN-C | Humans | Pancreatic Neoplasms - pathology | Treatment Outcome | Antineoplastic Agents - therapeutic use | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - drug therapy | Protein-Lysine 6-Oxidase - antagonists & inhibitors | Deoxycytidine - therapeutic use | Animals | Neoplasm Metastasis - prevention & control | Protein-Lysine 6-Oxidase - metabolism | Hypoxia | Mice | Deoxycytidine - analogs & derivatives | Oxidases | Prevention | Chemotherapy | Analysis | Collagen | Metastasis | Cancer | Adenocarcinoma | Medical research | Enzymes | Data analysis | Leukocyte migration | Gemcitabine | Leukocytes (neutrophilic) | Kinases | Macrophages | Metastases | Medical prognosis | Mutation | Cell migration | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women
by Block, Stan L and Nolan, Terry and Sattler, Carlos and Barr, Eliav and Giacoletti, Katherine E.D and Marchant, Colin D and Castellsague, Xavier and Rusche, Steven A and Lukac, Suzanne and Bryan, Janine T and Cavanaugh, Paul F., Jr and Reisinger, Keith S and Protocol 016 Study Group and Protocol 016 Study Grp and Protocol 016 Study Group and for the Protocol 016 Study Group
Pediatrics, ISSN 0031-4005, 11/2006, Volume 118, Issue 5, pp. 2135 - 2145
OBJECTIVE. Prophylactic vaccination of 16- to 23-year-old females with a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine... 
Vaccine | Immunogenicity | Pediatric | Reactogenicity | Noninferiority | HPV | ANTIBODIES | COST-EFFECTIVENESS | EFFICACY | PREVENTION | CERVICAL-CANCER | RANDOMIZED CONTROLLED-TRIAL | immunogenicity | noninferiority | pediatric | vaccine | reactogenicity | NEUTRALIZING EPITOPES | VIRUS-LIKE PARTICLES | PEDIATRICS | INFECTION | GENITAL WARTS | Papillomaviridae - immunology | Age Factors | Humans | Adolescent | Adult | Female | Male | Antibodies, Viral - blood | Child | Viral Vaccines - immunology | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Papillomavirus Vaccines | Prevention | Papillomavirus infections | Risk factors | Cervical cancer | Human papillomavirus | Immunization | Young adults | Mortality | Clinical trials | Comparative studies | Viruses | Teenagers | Vaccines | Children & youth
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine
by Rowhani-Rahbar, Ali and Mao, Constance and Hughes, James P and Alvarez, Frances B and Bryan, Janine T and Hawes, Stephen E and Weiss, Noel S and Koutsky, Laura A
Vaccine, ISSN 0264-410X, 2009, Volume 27, Issue 41, pp. 5612 - 5619
Abstract We conducted an extended follow-up study (March 2006–May 2008) to assess the longer term efficacy of a prophylactic monovalent human papillomavirus... 
Allergy and Immunology | Human papillomavirus type 16 | Efficacy | Prophylactic vaccines | MEDICINE, RESEARCH & EXPERIMENTAL | COST-EFFECTIVENESS | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | SUSTAINED EFFICACY | CERVICAL INTRAEPITHELIAL NEOPLASIA | SCREENING-PROGRAMS | QUADRIVALENT VACCINE | PARTICLE VACCINE | CANCER PREVENTION | YOUNG-WOMEN | Cervix Uteri - virology | Follow-Up Studies | Humans | Uterine Cervical Neoplasms - prevention & control | Human papillomavirus 16 - immunology | Young Adult | Vaccines, Virosome - immunology | Time Factors | Papillomavirus Infections - prevention & control | Adolescent | Capsid Proteins - immunology | Cervix Uteri - pathology | Female | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Placebos - administration & dosage | Papillomaviruses | Papillomavirus infections | Vaccines | Confidence intervals | Participation | Human papillomavirus | Womens health | Biopsy | Colleges & universities | Clinical trials | Infections | Family medical history | Cervical cancer | Public health | Combined vaccines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with the Linear Array HPV Genotyping PCR Assay and Influence of DNA Extraction Method on HPV Detection
by Christine C. Roberts and Ryan Swoyer and Janine T. Bryan and Frank J. Taddeo
Journal of Clinical Microbiology, ISSN 0095-1137, 05/2011, Volume 49, Issue 5, pp. 1899 - 1906
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
CERVICAL SPECIMENS | MICROBIOLOGY | INFECTIONS | CYTOLOGY | SAMPLES | VACCINE | Molecular Diagnostic Techniques - methods | Humans | DNA, Viral - isolation & purification | Specimen Handling - methods | Genitalia, Female - virology | Papillomaviridae - isolation & purification | Virology - methods | Papillomaviridae - genetics | Papillomavirus Infections - diagnosis | Polymerase Chain Reaction - methods | Papillomaviridae - classification | Sensitivity and Specificity | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Capsid Proteins - genetics | Virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone
by Sita Awasthi and John M. Lubinski and Carolyn E. Shaw and Shana M. Barrett and Michael Cai and Fushan Wang and Michael Betts and Susan Kingsley and Daniel J. DiStefano and John W. Balliet and Jessica A. Flynn and Danilo R. Casimiro and Janine T. Bryan and Harvey M. Friedman
Journal of Virology, ISSN 0022-538X, 10/2011, Volume 85, Issue 20, pp. 10472 - 10486
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
TYPE-1 FC-RECEPTOR | PROTEIN FACTOR-H | VIROLOGY | COMPLEMENT ACTIVATION | WEST-NILE-VIRUS | GENITAL HERPES | IN-VIVO | INFECTED-CELLS | IMMUNOGLOBULIN-G | T-CELLS | IMMUNE EVASION | Herpes Zoster - prevention & control | Herpes Zoster - immunology | Ganglia, Spinal - immunology | Guinea Pigs | Immunization - methods | Mice, Inbred C57BL | Secondary Prevention | Virus Shedding | Antibodies, Viral - blood | Herpes Zoster Vaccine - administration & dosage | Mice, Knockout | CD4-Positive T-Lymphocytes - immunology | Animals | Herpes Genitalis - prevention & control | Herpesvirus 2, Human - immunology | Vagina - virology | Female | Viral Envelope Proteins - immunology | Mice | Mice, Inbred BALB C | Herpes Genitalis - immunology | Antibodies, Neutralizing - blood | Herpes Zoster Vaccine - immunology | Vaccines and Antiviral Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights